Wasdell makes multimillion-pound investment in new packaging equipment
The contract packaging company has plans to install new equipment for the company’s blister and bottle lines, vial labelling, stability chambers and cold storage capacity.
Wasdell Group, a pharmaceutical outsourcing partner, has confirmed it is making a multimillion-pound investment in new packaging equipment across its UK and Ireland sites.
The specialist in end-to-end supply chain service provider made the decision to invest in line with increasing demand for its manufacturing and packaging capabilities from its growing pharma and biotech client portfolio.
The investment, which is part of a long-term investment plan to expand the company's capacity and capabilities, includes equipment for the company’s blister and bottle lines, vial labelling, stability chambers and cold storage capacity.
The equipment will be installed across all Wasdell’s sites in the UK and Ireland, including the recently opened Dundalk facility.
In addition to meeting increased demand, Vincent Dunne, CEO at Wasdell, explained the company's new packaging equipment will "allow us to maintain the swift turnaround times and flexible service we are well known for in the industry".
According to Martin Tedham, Wasdell Group Chairman, the investment will also support the company's expanding customer base, particularly US life sciences companies that want to "source a provider that can readily navigate the European market and specialises in small-mid batch sizes.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance